Coagulation studies as a prognostic index in acute liver failure

Area of Science:

• Hepatology
• Hematology
• Critical Care Medicine

Background:

• Acute liver failure (ALF) presents complex hemostatic challenges.
• Coagulation defects are common in ALF, impacting patient outcomes.
• Understanding these defects is crucial for prognosis assessment.

Purpose of the Study:

• To investigate coagulation abnormalities in ALF patients.
• To identify hematological parameters predicting survival in ALF.
• To assess the role of liver synthetic function in ALF prognosis.

Main Methods:

• Coagulation screening performed on 12 ALF patients (6 survivors, 6 non-survivors).
• Analysis of various hematological parameters for prognostic significance.
• Evaluation of factor-VII levels as an indicator of liver synthesis.
• Comparison with clot opacity fibrinogen technique.

Main Results:

• Fatal cases exhibited hemorrhagic states and hemostatic failure.
• Liver synthetic ability significantly correlated with survival prospects.
• Factor-VII levels showed a strong correlation with patient recovery.
• Clot opacity fibrinogen technique served as a viable prognostic guide when factor-VII assay was unavailable.
• Disseminated intravascular coagulation (DIC) status did not determine survival in this cohort.

Conclusions:

• Liver synthetic function is a critical determinant of survival in acute liver failure.
• Factor-VII assay is a valuable tool for assessing prognosis in ALF.
• Alternative methods like clot opacity fibrinogen assay can provide prognostic insights.